In an interview with Arthur Stril, chief business officer and interim CFO at Cellectis, we explore how gene editing and ...

Vaccine manufacturer Bharat Biotech International Limited (BBIL) is making a foray into the cell and gene therapy (CGT) space ...

Bharat Biotech invests $75 million in India's first Cell & Gene Therapy facility, focusing on advanced therapies and ...

Bharat Biotech International Limited (BBIL), a pioneer in affordable indigenous vaccine development and manufacturing, ...

Three car attacks have led to injuries and loss of life in German towns in the space of mere weeks. A fatal car ramming in a crowded German city square has refocused attention on the use of ...

A fatal car ramming in a crowded German city square has refocused attention on the use of vehicles by people seeking to ...

AstraZeneca has entered the “off-the-shelf” cell therapy space, penning a $1 billion deal to acquire EsoBiotec and its ...

EsoBiotec’s platform has the potential to eliminate the complex and time-consuming process for manufacturing, helping to make CAR-T cell therapies more accessible.

Bharat Biotech aims to democratize gene therapies, traditionally considered prohibitively expensive and available primarily ...

Alain Guiraudie’s intimate thriller, about sex and death in a rustic village, bends classic tropes into modern forms.

He was one of the few ICU patients whose face I saw in early 2021, when COVID raged through Los Angeles. As a palliative-care ...

Zevor-cel was approved by China's National Medical Products Administration (NMPA). <li /> As of December 31, 2024, ...